The professional's guide to product selection
Non-sedating antihistamine.
• Child 1–5 years: 1.25 mg once daily.
• Child 6–11 years: 2.5 mg once daily.
• Over 12 years: 5 mg once daily.
Non-sedating antihistamine.
• Child 1–5 years: 1.25 mg once daily.
• Child 6–11 years: 2.5 mg once daily.
• Over 12 years: 5 mg once daily.
Non-sedating antihistamine.
• Child 1–5 years: 1.25 mg once daily.
• Child 6–11 years: 2.5 mg once daily.
• Over 12 years: 5 mg once daily.
Suppression of inflammatory and allergic disorders by mouth
• Child: 10–100 mcg/kg daily in 1–2 divided doses.
• Adult: 0.5–10 mg daily.
Mild croup by mouth
Child: 150 mcg/kg for 1 dose
Severe croup by mouth
Child: initially 150 mcg/kg before transfer to hospital, then an additional dose, then another after 12 hours if required.
Dyspnoea due to bronchospasm or partial obstruction in palliative care
Adult: 4–8 mg daily.
Suppression of inflammatory and allergic disorders by mouth
• Child: 10–100 mcg/kg daily in 1 or 2 divided doses. Up to 300 mcg/kg can be given in emergency situations.
• Adult: 0.5–10 mg daily.
Mild croup by mouth
• Child: 150 mcg/kg for 1 dose.
Severe croup by mouth
• Child: initially 150 mcg/kg before transfer to hospital, then an additional dose, then another after 12 hours if required.
Dyspnoea due to bronchospasm or partial obstruction in palliative care
• Adult: 4–8 mg daily.
Covid-19 requiring supplemental oxygen
• Child: 150 mcg/kg once daily (max. per dose 6 mg) for 10 days, or until the day of discharge if this is sooner.
• Adult: 6 mg once daily for 10 days, or until the day of discharge if this is sooner.
Suppression of inflammatory and allergic disorders by mouth
• Child: 10–100 mcg/kg daily in 1–2 divided doses.
• Adult: 0.5–10 mg daily.
Mild croup by mouth
Child: 150 mcg/kg for 1 dose
Severe croup by mouth
Child: initially 150 mcg/kg before transfer to hospital, then an additional dose, then another after 12 hours if required.
Dyspnoea due to bronchospasm or partial obstruction in palliative care
Adult: 4–8 mg daily.
Suppression of inflammatory and allergic disorders by mouth
• Child: 10–100 mcg/kg daily in 1–2 divided doses.
• Adult: 0.5–10 mg daily.
Mild croup by mouth
Child: 150 mcg/kg for 1 dose
Severe croup by mouth
Child: initially 150 mcg/kg before transfer to hospital, then an additional dose, then another after 12 hours if required.
Dyspnoea due to bronchospasm or partial obstruction in palliative care
Adult: 4–8 mg daily.
Suppression of inflammatory and allergic disorders by mouth
• Child: 10–100 mcg/kg daily in 1–2 divided doses.
• Adult: 0.5–10 mg daily.
Mild croup by mouth
Child: 150 mcg/kg for 1 dose
Severe croup by mouth
Child: initially 150 mcg/kg before transfer to hospital, then an additional dose, then another after 12 hours if required.
Dyspnoea due to bronchospasm or partial obstruction in palliative care
Adult: 4–8 mg daily.
Suppression of inflammatory and allergic disorders by mouth
• Child: 10–100 mcg/kg daily in 1–2 divided doses.
• Adult: 0.5–10 mg daily.
Mild croup by mouth
Child: 150 mcg/kg for 1 dose
Severe croup by mouth
Child: initially 150 mcg/kg before transfer to hospital, then an additional dose, then another after 12 hours if required.
Dyspnoea due to bronchospasm or partial obstruction in palliative care
Adult: 4–8 mg daily.
Suppression of inflammatory and allergic disorders by mouth
• Child: 10–100 mcg/kg daily in 1–2 divided doses.
• Adult: 0.5–10 mg daily.
Mild croup by mouth
Child: 150 mcg/kg for 1 dose
Severe croup by mouth
Child: initially 150 mcg/kg before transfer to hospital, then an additional dose, then another after 12 hours if required.
Dyspnoea due to bronchospasm or partial obstruction in palliative care
Adult: 4–8 mg daily.